levalbuterol tartrate
levalbuterol tartrate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Levalbuterol tartrate HFA inhalation, XOPENEX HFA. Available dosage form: aerosol, metered.
Drug details
- Generic Name
- levalbuterol tartrate
- Brand Names
- Levalbuterol tartrate HFA inhalation, XOPENEX HFA
- Application Number
- NDA021730
- Sponsor
- Proficient Rx LP
- NDC Codes
- 3
- Dosage Forms
- AEROSOL, METERED
- Routes
- ORAL
- Active Ingredients
- LEVALBUTEROL TARTRATE
Indications and Usage
1 INDICATIONS AND USAGE XOPENEX HFA is a beta 2 -adrenergic agonist indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. ( 1.1 ) 1.1 Bronchospasm XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.